Yanping Wang, MD, received her medical degree from Norman Bethune University of Medical Science in China. She joined the Kim Laboratory in 2006. Her research focuses on immunotherapy for urologic cancer.
Shengchen Su, PhD, received her doctorate in biology from Virginia Polytechnic Institute and State University. She joined the Kim Laboratory in 2018. Her research focuses on identifying and validating the predictive makers of angiogenesis inhibitor treatment for clear cell renal carcinoma.